Glaukos Corporation Net Income 2011-2025 | GKOS

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.^[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Glaukos Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-135 M	-99.2 M	-49.6 M	-120 M	15.4 M	-13 M	-92 K	4.52 M	-37.2 M	-12.1 M	-12.6 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.4 M	-135 M	-41.7 M

Quarterly Net Income Glaukos Corporation

2025-Q2	2025-Q1	2024-Q4	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-19.7 M	-18.1 M	-	-50.5 M	-40.8 M	-	-30.4 M	-32.8 M	-34.6 M	-	-27.6 M	-45.5 M	5.38 M	-21.9 M	6.23 M	-17.5 M	-16.5 M	-10.6 M	-15.7 M	-39.9 M	-54.1 M	36.6 M	-13.5 M	-6.31 M	-1.34 M	1.78 M	-6.62 M	-5.4 M	-2.71 M	1.01 M	1.32 M	-3.3 M	878 K	134 K	1.16 M	2.33 M	897 K	-2.29 M	-2.06 M	-31.9 M	-966 K	-4.61 M	-1.49 M	-2.07 M	-3.96 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.6 M	-54.1 M	-12.1 M

References

Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical instruments industry

Issuer	Net Income	Price	% 24h	Market Cap	Country
BioLife Solutions BLFS	-20.2 M	$ 24.56	0.7 %	$ 1.13 B	USA
Baxter International BAX	-512 M	$ 19.52	1.93 %	$ 9.96 B	USA
Becton, Dickinson and Company BDX	1.68 B	$ 200.48	-0.23 %	$ 57.7 B	USA
Luminex Corporation LMNX	15.2 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	-17.6 M	-	-9.52 %	$ 20.6 M	USA
Ekso Bionics Holdings EKSO	-11.3 M	$ 4.68	0.21 %	$ 94.4 M	USA
Antares Pharma, Inc. ATRS	56.2 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	13.7 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	-24.5 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	223 M	-	-0.05 %	$ 10.3 B	USA
Harvard Bioscience HBIO	-3.42 M	$ 0.71	-4.45 %	$ 30.1 M	USA
Varian Medical Systems, Inc. VAR	292 M	-	-0.02 %	$ 16.3 B	USA
ICU Medical ICUI	-118 M	$ 148.28	-0.1 %	$ 3.62 B	USA
iRhythm Technologies IRTC	-113 M	$ 170.21	0.82 %	$ 5.31 B	USA
Alcon ALC	376 M	$ 79.15	0.43 %	$ 40.4 B	Schweiz
AtriCure ATRC	-44.7 M	$ 41.07	-3.09 %	$ 1.93 B	USA
Atrion Corporation ATRI	19.4 M	-	-	$ 810 M	USA
electroCore ECOR	-18.8 M	$ 4.85	2.11 %	$ 26.7 K	USA
Repro Med Systems KRMD	-13.7 M	$ 5.8	0.35 %	$ 264 M	USA
AngioDynamics ANGO	-34 M	$ 13.42	2.13 %	$ 548 M	USA
The Cooper Companies COO	375 M	$ 81.36	-0.88 %	$ 16.2 B	USA
LeMaitre Vascular LMAT	44 M	$ 83.04	-1.14 %	$ 1.86 B	USA
Masimo Corporation MASI	-305 M	$ 137.35	-0.72 %	$ 7.32 B	USA
Haemonetics Corporation HAE	168 M	$ 80.24	-3.89 %	$ 4.04 B	USA
InfuSystem Holdings INFU	18 K	$ 9.22	-0.27 %	$ 190 M	USA
Merit Medical Systems MMSI	120 M	$ 86.49	-0.24 %	$ 5.04 B	USA
Isoray ISR	-79.3 M	-	0.03 %	$ 108 M	USA
Intuitive Surgical ISRG	2.32 B	$ 559.7	3.2 %	$ 199 B	USA
OraSure Technologies OSUR	-19.5 M	$ 2.49	-	$ 185 M	USA
Microbot Medical MBOT	-10.7 M	$ 2.23	-7.65 %	$ 22.7 M	Israel
Milestone Scientific MLSS	-4.71 M	$ 0.36	-7.4 %	$ 28.7 M	USA
Nephros NEPH	-1.58 M	$ 4.98	-0.8 %	$ 51.7 M	USA
NeuroMetrix NURO	-7.81 M	-	5.05 %	$ 9.02 M	USA
ResMed RMD	779 M	$ 251.67	-0.27 %	$ 36.8 B	USA
Envista Holdings Corporation NVST	-1.12 B	$ 22.07	0.46 %	$ 3.8 B	USA
Pro-Dex PDEX	8.98 M	$ 44.0	1.43 %	$ 145 M	USA
STAAR Surgical Company STAA	-20.2 M	$ 23.49	-2.65 %	$ 1.15 B	USA
STERIS plc STE	615 M	$ 253.98	0.82 %	$ 25 B	USA
Stereotaxis STXS	-20.7 M	$ 2.35	-1.05 %	$ 190 M	USA
Pulse Biosciences PLSE	-42.2 M	$ 14.04	-1.4 %	$ 674 M	USA
Predictive Oncology POAI	-12.7 M	-	-	$ 32.4 M	USA
Repligen Corporation RGEN	35.6 M	$ 160.09	1.72 %	$ 8.92 M	USA
Utah Medical Products UTMD	4.29 M	$ 57.54	-0.96 %	$ 209 M	USA
DENTSPLY SIRONA XRAY	-910 M	$ 11.43	-1.21 %	$ 2.32 B	USA
Retractable Technologies RVP	-11.9 M	$ 0.84	1.99 %	$ 25.1 M	USA
Teleflex Incorporated TFX	69.7 M	$ 126.88	0.17 %	$ 5.94 B	USA
West Pharmaceutical Services WST	493 M	$ 271.82	1.6 %	$ 19.8 B	USA